Functional anterior pituitary generated in self-organizing culture of human embryonic stem cells
Source Ozone et al., 2016 · RIKEN Center for Developmental Biology · 10.1038/ncomms10351
Abstract
This protocol describes a three-dimensional self-organizing culture method (SFEBq) for differentiating human embryonic stem cells into functional anterior pituitary tissue capable of producing multiple hormone-producing cell types, including corticotrophs and somatotrophs that respond to physiological releasing and feedback signals. The generated pituitary progenitors differentiate into mature hormone-producing cells with demonstrated functional responses, and transplantation of in vitro-generated corticotrophs rescues hypopituitary mice.
Protocol overview
21 steps across 5 phases
- 1 Maintain undifferentiated hESCs on feeder layer
- 2 Prepare hESCs for SFEBq aggregation
- 3 Add medium on day 3
- 1 Initiate hedgehog signalling and BMP4 treatment
- 2 Promote Rathke's pouch formation with FGF2
- 3 Switch to suspension culture and increase KSR
- 1 Support corticotroph development
- 2 Induce somatotroph differentiation with dexamethasone
- 3 Induce gonadotroph differentiation with Notch inhibitor
- 1 Test corticotroph CRH responsiveness
- 2 Test glucocorticoid feedback suppression
- 3 Test somatotroph GHRH responsiveness
- 4 Test somatostatin-mediated GH suppression
- 1 Prepare tissue for transplantation
- 2 Perform surgical hypophysectomy on SCID mice
- 3 Transplant pituitary tissue into kidney subcapsule
- 4 Perform CRH loading test in vivo
- 5 Measure corticosterone response
- 6 Assess spontaneous locomotor activity
- 7 Monitor body weight and survival
- 8 Assess long-term graft integration and vascularization
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Ozone et al., 2016. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol